Skip to main content
Edward Meyer, MD, Endocrinology, Fremont, CA

EdwardJohnMeyerMD

Endocrinology Fremont, CA

Diabetes, Pituitary Disorders & Neuroendocrinology

Physician

Dr. Meyer is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Meyer's full profile

Already have an account?

  • Office

    2333 Mowry Ave
    Ste 300
    Fremont, CA 94538
    Phone+1 530-899-9112
    Fax+1 530-899-0142

Education & Training

  • Oregon Health & Science University (OHSU Health)
    Oregon Health & Science University (OHSU Health)Residency, Internal Medicine, 1972 - 1975
  • Oregon Health  Science University Hospital
    Oregon Health Science University HospitalInternship, Transitional Year, 1971 - 1972
  • University of California San Francisco School of Medicine
    University of California San Francisco School of MedicineClass of 1971

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 1972 - 2025
  • American Board of Internal Medicine Internal Medicine

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification eClinicalWorks EHR, eClinicalWorks LLC, 2013
  • Fellow (FACE) American Association of Clinical Endocrinology

Press Mentions

  • DoD $6.5m to NYC’s Weill Cornell Medicine to Develop Breast Cancer Research Center of Excellence
    DoD $6.5m to NYC’s Weill Cornell Medicine to Develop Breast Cancer Research Center of ExcellenceDecember 12th, 2021
  • Department of Defense Awards Weill Cornell Medicine New Grant for Breast Cancer Research
    Department of Defense Awards Weill Cornell Medicine New Grant for Breast Cancer ResearchDecember 9th, 2021
  • Combination Therapy Boosts Lung Cancer Patients’ Response, Cuts Treatment Time in Phase 2 Trial
    Combination Therapy Boosts Lung Cancer Patients’ Response, Cuts Treatment Time in Phase 2 TrialJune 15th, 2021
  • Join now to see all

Professional Memberships